about
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and ef...
Read More
5.78
0.12
(2.12%)
2.8M
XNAS Volume
XNAS 13 Mar, 2026 5:30 PM (EDT)
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution
View Similar
Embed DVM
Ardelyx Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..